Clinical commentaryAn inevitable dilemma: Prenatal testing for mutations in the brca1 breast-ovarian cancer susceptibility gene**
References (19)
- et al.
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
Lancet
(1994) - et al.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
Science
(1994) - et al.
A collaborative survey of 80 mutations in the BRCA1 breast, ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening
JAMA
(1995) - et al.
The Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers
Am J Hum Genet
(1995) - et al.
Localization of a breast cancer susceptibility gene BRCA2, to chromosome 13ql2-13
Science
(1994) - et al.
A single ataxia telangiectasia gene with a product similar to PI-3 kinase
Science
(1995) - et al.
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals
J Natl Cancer Inst
(1992) - et al.
Rapid detection of BRCA1 mutations by the protein trunction test
Nature Genetics
(1995) - et al.
Assessment and counseling for women with a family history of breast cancer
JAMA
(1995)
There are more references available in the full text version of this article.
Cited by (0)
- **
Supported in part by National Institutes of Health grant CA55640 (AB).
Copyright © 1996 Published by Elsevier Inc.